Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-07-02Clinical Trial Results: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
Clinical trial results for adapting multiple behavior interventions to improve cancer survivor health; completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma [Phase 2]
Phase 2 trial evaluating cadonilimab with chemoradiation for recurrent and oligometastatic endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer [Phase 3]
Phase 3 clinical trial evaluating bevacizumab added to carboplatin and paclitaxel with pembrolizumab for advanced or recurrent endometrial c…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer [Phase 3]
Phase 3 clinical trial sponsored by BioNTech SE evaluating an unnamed investigational therapy for endometrial cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 ComboMATCH trial evaluating neratinib alone or with palbociclib for HER2-positive solid tumors, including malignant neoplasms of the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial [Phase 2]
Phase 2 screening trial (ComboMATCH) sponsored by the National Cancer Institute uses genetic testing to direct targeted therapies for patien…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma [Phase 2]
Phase 2 study evaluating pembrolizumab plus olaparib for endometrial cancer and endometrial carcinosarcoma is currently active but not recru…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer [NA]
Clinical trial comparing proton therapy to intensity-modulated radiation therapy after surgery for cervical and endometrial cancer; the stud…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Laparotomy vs Laparoscopy in Endometrial Cancer Staging [NA]
A clinical trial comparing laparotomy versus laparoscopy for staging endometrial cancer, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer (Phase 1)
This clinical trial update describes a Phase 1 study (SHAPE-ENDO) evaluating multimodal pre-surgical optimization for patients with obesity …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Endometrial Cancer Vaginal Fluid Specimen Collection Study
ClinicalTrials.gov updates an ongoing Exact Sciences study recruiting participants to evaluate vaginal fluid specimen collection related to …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial [Phase 2]
Phase 2 study evaluating the combination of selumetinib with olaparib, or selumetinib alone, for RAS pathway-mutant recurrent or persistent …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Vaginal Cuff Brachytherapy Fractionation Study [Phase 3]
A Phase 3 clinical trial update for vaginal cuff brachytherapy fractionation in endometrial cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Signatera Assessment in Early-Stage Endometrial Cancer [NA]
ClinicalTrials.gov entry indicates a Signatera assessment in early-stage endometrial cancer, with the study currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of PHST001 in Advanced Solid Tumors [Phase 1]
Pheast Therapeutics is recruiting for a Phase 1 study of PHST001 in patients with advanced solid tumors, including ovarian cancer, endometri…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Tirzepatide in Obesity-Driven Endometrial Cancer [EARLY_Phase 1]
An early phase 1 trial is evaluating tirzepatide for obesity-driven endometrial cancer and it is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors [Phase 1]
This clinical trial update indicates Regor Pharmaceuticals' investigational drug RGT-490 is being studied in a Phase 1 trial for patients wi…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4175408 in Participants With Advanced Cancer [Phase 1]
A Phase 1 clinical trial evaluating LY4175408 in participants with advanced cancers, including non-small cell lung cancer, small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
A Mayo Clinic-sponsored clinical trial is evaluating methylated DNA markers to detect endometrial, ovarian, and cervical cancers, with recru…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4257496 in Participants With Cancer (OMNIRAY) [Phase 1]
Phase 1 clinical trial update for LY4257496 in cancer patients; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain [Phase 3]
A Phase 3 clinical trial in Spain is evaluating first-line durvalumab with platinum-based chemotherapy followed by durvalumab plus olaparib …